Cargando…
Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks
Stapled peptides targeting the interaction between p53 and its negative regulators MDM2 and MDM4 have exhibited great potential as anti-cancer drugs, albeit with room for improvement in formulation and tumor specificity. Lipid bilayer disks (lipodisks) have emerged as promising drug nanocarriers and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221704/ https://www.ncbi.nlm.nih.gov/pubmed/32325827 http://dx.doi.org/10.3390/nano10040783 |
_version_ | 1783533422428291072 |
---|---|
author | Lundsten, Sara Hernández, Víctor Agmo Gedda, Lars Sarén, Tina Brown, Christopher J. Lane, David P. Edwards, Katarina Nestor, Marika |
author_facet | Lundsten, Sara Hernández, Víctor Agmo Gedda, Lars Sarén, Tina Brown, Christopher J. Lane, David P. Edwards, Katarina Nestor, Marika |
author_sort | Lundsten, Sara |
collection | PubMed |
description | Stapled peptides targeting the interaction between p53 and its negative regulators MDM2 and MDM4 have exhibited great potential as anti-cancer drugs, albeit with room for improvement in formulation and tumor specificity. Lipid bilayer disks (lipodisks) have emerged as promising drug nanocarriers and can by attachment of targeting moieties be directed selectively towards tumor cells. Tumor-targeted delivery of stapled peptides by use of lipodisks may therefore increase the uptake in the tumors and limit toxicity in healthy tissue. Here, we utilized epidermal growth factor receptor (EGFR)-targeted lipodisks to deliver p53-activating stapled peptide VIP116 to EGFR-expressing tumor cells. We demonstrate that VIP116 can be stably formulated in lipodisks (maximum peptide/lipid molar ratio 0.11). In vitro cell studies verify specific binding of EGF-decorated lipodisks to tumor cells and confirm that targeted delivery of VIP116 significantly decreases tumor cell viability. |
format | Online Article Text |
id | pubmed-7221704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72217042020-05-21 Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks Lundsten, Sara Hernández, Víctor Agmo Gedda, Lars Sarén, Tina Brown, Christopher J. Lane, David P. Edwards, Katarina Nestor, Marika Nanomaterials (Basel) Communication Stapled peptides targeting the interaction between p53 and its negative regulators MDM2 and MDM4 have exhibited great potential as anti-cancer drugs, albeit with room for improvement in formulation and tumor specificity. Lipid bilayer disks (lipodisks) have emerged as promising drug nanocarriers and can by attachment of targeting moieties be directed selectively towards tumor cells. Tumor-targeted delivery of stapled peptides by use of lipodisks may therefore increase the uptake in the tumors and limit toxicity in healthy tissue. Here, we utilized epidermal growth factor receptor (EGFR)-targeted lipodisks to deliver p53-activating stapled peptide VIP116 to EGFR-expressing tumor cells. We demonstrate that VIP116 can be stably formulated in lipodisks (maximum peptide/lipid molar ratio 0.11). In vitro cell studies verify specific binding of EGF-decorated lipodisks to tumor cells and confirm that targeted delivery of VIP116 significantly decreases tumor cell viability. MDPI 2020-04-19 /pmc/articles/PMC7221704/ /pubmed/32325827 http://dx.doi.org/10.3390/nano10040783 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Lundsten, Sara Hernández, Víctor Agmo Gedda, Lars Sarén, Tina Brown, Christopher J. Lane, David P. Edwards, Katarina Nestor, Marika Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks |
title | Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks |
title_full | Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks |
title_fullStr | Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks |
title_full_unstemmed | Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks |
title_short | Tumor-Targeted Delivery of the p53-Activating Peptide VIP116 with PEG-Stabilized Lipodisks |
title_sort | tumor-targeted delivery of the p53-activating peptide vip116 with peg-stabilized lipodisks |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221704/ https://www.ncbi.nlm.nih.gov/pubmed/32325827 http://dx.doi.org/10.3390/nano10040783 |
work_keys_str_mv | AT lundstensara tumortargeteddeliveryofthep53activatingpeptidevip116withpegstabilizedlipodisks AT hernandezvictoragmo tumortargeteddeliveryofthep53activatingpeptidevip116withpegstabilizedlipodisks AT geddalars tumortargeteddeliveryofthep53activatingpeptidevip116withpegstabilizedlipodisks AT sarentina tumortargeteddeliveryofthep53activatingpeptidevip116withpegstabilizedlipodisks AT brownchristopherj tumortargeteddeliveryofthep53activatingpeptidevip116withpegstabilizedlipodisks AT lanedavidp tumortargeteddeliveryofthep53activatingpeptidevip116withpegstabilizedlipodisks AT edwardskatarina tumortargeteddeliveryofthep53activatingpeptidevip116withpegstabilizedlipodisks AT nestormarika tumortargeteddeliveryofthep53activatingpeptidevip116withpegstabilizedlipodisks |